NASDAQ: IKT

3.85% percent quarterly performance for Inhibikase Therapeutics Inc (IKT) is not indicative of the underlying story
Steve Mayer
Inhibikase Therapeutics Inc (NASDAQ: IKT) kicked off on Monday, up 5.19% from the previous trading day, before settling in for ...





